| IV-69 Eric Salgado Target engagement analysis of belimumab in patients with systemic lupus erythematosus (SLE) and primary Sjogren’s syndrome (pSS) Thursday 15:25-16:55 |
| IV-69 Eric Salgado Target engagement analysis of belimumab in patients with systemic lupus erythematosus (SLE) and primary Sjogren’s syndrome (pSS) Thursday 15:25-16:55 |